Development and characterization of novel photosensitizer : scFv conjugates for use in photodynamic therapy of cancer
β Scribed by Chrysovalanto Staneloudi; Karen A. Smith; Robert Hudson; Nela Malatesti; Huguette Savoie; Ross W. Boyle; John Greenman
- Book ID
- 108782016
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 590 KB
- Volume
- 120
- Category
- Article
- ISSN
- 0019-2805
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Coupling of photosensitizers to tumor-selective monoclonal antibodies (MAbs) is an attractive option for improving the selectivity of photodynamic therapy (PDT). For this purpose, hydrophilic sensitizers would be most suitable because of their solubility in water. However, such sensitizers are known
## Abstract To homogenize light emitted from fiber optic diffusers for photodynamic therapy (PDT), novel coating materials with tunable properties were designed. A class VI medical grade UVβcurable acrylic resin for biomedical applications was used for the polymer matrix, and titanium dioxide (TiO~
## Background and Objective : Three prototype microchannelcooled stacked diode array lasers were compared with the currently used conventional argon ion laser-pumped tunable dye lasers for suitability as light sources in photodynamic therapy (PDT) treatment. Study Design/Materials and Methods: The
## Abstract ## Background and Objective A human glioma spheroid model is used to investigate the efficacy of different light delivery schemes in 5βaminolevulinic acid (ALA)βmediated photodynamic therapy (PDT). The results provide the rationale for the development of an indwelling balloon applicato